March 25, 2025 Breaking Down Research: Investigation of Urinary miRNAs for Early Detection of Kidney Damage in selected lab animals Drug-induced kidney injury is commonly identified during drug development and serves as a dose-limiting factor...
March 24, 2025 Lysosomal Storage Disease Data Sharing Workshop, Webinar Series Session #2: Case Studies #1 – Proactive Data Sharing This webinar from Critical Path Institute's Critical Path to Lysosomal Diseases Consortium presents...
March 24, 2025 A Tutorial and Use Case Example of the eXtreme Gradient Boosting (XGBoost) Artificial Intelligence Algorithm for Drug Development Applications Approaches to artificial intelligence and machine learning (AI/ML) continue to advance in the field of drug development.
The Critical Path Institute Podcast: Connecting the Dots with COA VP Dr. Cheryl Coon If you have attended one of C-Path’s stakeholder meetings, read one of our impact stories or engaged through our social...
March 21, 2025 Wrangling Real-World Data: Optimizing Clinical Research Through Factor Selection with LASSO Regression Data-driven approaches to clinical research are necessary for understanding and effectively treating infectious diseases.
April 17, 2025 ACE Inhibitors as a Cardioprotective Treatment in Dystrophinopathies ACE inhibitors were the first pharmacological class shown to benefit heart failure treatment...
March 13, 2025 Principles of good practice for translation of electronic clinical outcome assessments While many publications have outlined good practice recommendations for translation and electronic implementation of clinical...
March 10, 2025 C-Path’s Critical Path for Parkinson’s Consortium Welcomes CND Life Sciences C-Path is excited to welcome CND Life Sciences as the newest member of it Critical Path for Parkinson’s (CPP) Consortium. CND Li
New Biomarkers Could Improve Early Detection, Monitoring of Kidney Injury C-Path and Boston Medical Center published results for six biomarkers that could improve the early and accurate detection...
C-Path Announces Steven W. Spector and James A. King as New Board Members C-Path announced the appointments of Steven W. Spector and James A. King to its Board of Directors...
